Viral Vaccine Lot Release Package

WuXi Advanced Therapies is now offering a comprehensive viral vaccine lot release package. This package includes a range of assays to ensure the quality and safety of the vaccine, such as titer determination, potency assay, gene sequencing, and detection of adventitious agents. Additional tests cover residuals, general characteristics, osmolality, and extractable volume. We also provides services like cell banking and viral clearance studies. All testing is conducted in compliance with current Good Manufacturing Practices (cGMP).

With over 20 years of experience, WuXi Advanced Therapies has supported numerous Cell and Gene Therapy clients and understands the importance of timely lot release testing. We have a proven track record, having successfully completed over 50 commercial lot release programs. Our dedicated testing facility, Rouse 400 (R400), is located in Philadelphia and has received regulatory approval from agencies like the EMA, TGA, Health Canada, and FDA.